Literature DB >> 16632103

Familial pancreatic cancer syndromes.

Nils Habbe1, Peter Langer, Mercedes Sina-Frey, Detlef K Bartsch.   

Abstract

Hereditary pancreatic cancer (PC) is rare and extremely heterogeneous, and it accounts for approximately 2% of all PC cases. The major component of hereditary PC is the familial pancreatic cancer syndrome. Although up to 20% of hereditary PC cases are associated with germline mutations in the BRCA2, CDKN2A, PRSS1,STKI1, or MMR genes, the major underlying gene defect(s) is still unknown. Although hereditary PC is rare, the data on PC families that have been collected by various study groups worldwide provide a unique opportunity to evaluate the natural history, causative gene alterations, new diagnosis and chemoprevention strategies as well as treatment modalities.

Entities:  

Mesh:

Year:  2006        PMID: 16632103     DOI: 10.1016/j.ecl.2006.02.016

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  20 in total

Review 1.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  [Prophylactic pancreas surgery].

Authors:  P Langer; M Rothmund; D K Bartsch
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 3.  The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Authors:  Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

Review 4.  Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group.

Authors:  P Pérez Segura; C Guillén Ponce; T Ramón Y Cajal; R Serrano Blanch; E Aranda
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

5.  BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.

Authors:  Eswary Thirthagiri; Kimberly D Klarmann; Anil K Shukla; Eileen Southon; Kajal Biswas; Betty K Martin; Susan Lynn North; Valentin Magidson; Sandra Burkett; Diana C Haines; Kathleen Noer; Roberta Matthai; Lino Tessarollo; Jadranka Loncarek; Jonathan R Keller; Shyam K Sharan
Journal:  Hum Mol Genet       Date:  2016-02-26       Impact factor: 6.150

Review 6.  KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

Authors:  John P Morris; Sam C Wang; Matthias Hebrok
Journal:  Nat Rev Cancer       Date:  2010-09-03       Impact factor: 60.716

7.  DNA repair gene polymorphisms and risk of pancreatic cancer.

Authors:  Donghui Li; Hideo Suzuki; Bingrong Liu; Jeffrey Morris; Jun Liu; Taro Okazaki; Yanan Li; Ping Chang; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma.

Authors:  Reena Shakya; Tamas Gonda; Michael Quante; Martha Salas; Samuel Kim; Jenna Brooks; Steffen Hirsch; Justine Davies; Angelica Cullo; Kenneth Olive; Timothy C Wang; Matthias Szabolcs; Benjamin Tycko; Thomas Ludwig
Journal:  Cancer Res       Date:  2012-11-29       Impact factor: 12.701

Review 9.  Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Authors:  Gabriele Lami; Maria Rosa Biagini; Andrea Galli
Journal:  World J Gastrointest Endosc       Date:  2014-07-16

10.  Role of the mismatch repair gene, Msh6, in suppressing genome instability and radiation-induced mutations.

Authors:  Julio Barrera-Oro; Tzu-Yang Liu; Erin Gorden; Raju Kucherlapati; Changshun Shao; Jay A Tischfield
Journal:  Mutat Res       Date:  2008-04-30       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.